Dr Andrew Paul
Senior Lecturer
Strathclyde Institute of Pharmacy and Biomedical Sciences
Personal statement
Andy holds a Senior Lectureship position in the Strathclyde Institute of Pharmacy and Biomedical Sciences at the University of Strathclyde and has 20 years experience of research and teaching across the Biomedical Science (BMS) and Pharmacy (MPharm) programmes related to application of protein biochemistry and molecular pharmacology, in the context of cellular signalling, to health and disease. Andy is a graduate of the University of Glasgow (BSc (Hons) Biochemistry; 1986-1990) and completed his second degree (PhD Biochemistry & Molecular Biology, 1990-1993) at the University of Glasgow in association with the Wellcome Foundation, Beckenham.
The work in Andy's research lab focusses on the role of the inhibitory kappaB kinases (IKKs) in the regulation of both Nuclear Factor kappaB (NFkappaB)-dependent and -independent transcription in mediating inflammatory-based responses relevant to infection, regulation of immunity, cardiovascular disease and cancer.
Publications
- IL-1β stimulates a novel axis within the NFκB pathway in endothelial cells regulated by IKKα and TAK-1
- Craig Rachel, McIntosh Kathryn, Ho Ka Ho, McCulloch Ashley, Riley Christopher, Lawson Christopher, MacKay Simon P, Paul Andrew, Coats Paul, Plevin Robin
- Biochemical Pharmacology Vol 232 (2025)
- https://doi.org/10.1016/j.bcp.2024.116736
- Design and synthesis of novel aminoindazole-pyrrolo[2,3-b]pyridine inhibitors of IKKα that selectively perturb cellular non-canonical NF-κB signalling
- Riley Christopher, Ammar Usama, Alsfouk Aisha, Anthony Nahoum G, Baiget Jessica, Berretta Giacomo, Breen David, Huggan Judith, Lawson Christopher, McIntosh Kathryn, Plevin Robin, Suckling Colin J, Young Louise C, Paul Andrew, Mackay Simon P
- Molecules Vol 29 (2024)
- https://doi.org/10.3390/molecules29153515
- IL-1β stimulates a novel, IKKα -dependent, NIK -independent activation of non-canonical NFκB signalling
- McIntosh Kathryn, Khalaf Yousif H, Craig Rachel, West Christopher, McCulloch Ashley, Waghmare Ajay, Lawson Christopher, Chan Edmond YW, MacKay Simon, Paul Andrew, Plevin Robin
- Cellular Signalling Vol 107 (2023)
- https://doi.org/10.1016/j.cellsig.2023.110684
- Interleukin-1b stimulates a novel early activation of non-canonical NF Kappa B signalling pathway linked to CXCL12 production.
- McIntosh Kathryn, Craig Rachel Georgina, McCulloch Ashley, MacKay Simon, Paul Andrew, Plevin Robin
- British Pharmacology annual conference (2022)
- Determining the prognostic significance of IKKα in prostate cancer
- Montes Melania, MacKenzie Lewis, McAllister Milly J, Roseweir Antonia, McCall Pamela, Hatziieremia Sophia, Underwood Mark A, Boyd Marie, Paul Andrew, Plevin Robin, MacKay Simon P, Edwards Joanne
- The Prostate Vol 80, pp. 1188-1202 (2020)
- https://doi.org/10.1002/pros.24045
- Compromised cardiovascular function in aged rats corresponds with increased expression and activity of calcium/calmodulin dependent protein kinase IIδ in aortic endothelium
- McCluskey Claire, Mooney Laura, Paul Andrew, Currie Susan
- Vascular pharmacology Vol 118-119 (2019)
- https://doi.org/10.1016/j.vph.2019.04.002
Professional Activities
- EMBO/FEBS Conference , Spain
- Keynote/plenary speaker
- 1/2008
Projects
- MRC-DPFS Full Application 2023 - Targeting Inhibitory kappa B kinase alpha (IKKalpha): a new treatment paradigm for inflammatory-driven cancers
- MacKay, Simon (Principal Investigator) Paul, Andrew (Co-investigator)
- 01-Jan-2024 - 31-Jan-2027
- Development of a first-in-class IKKalpha inhibitor for the treatment of castrate resistant p
- MacKay, Simon (Principal Investigator) Halbert, Gavin (Co-investigator) Paul, Andrew (Co-investigator) Suckling, Colin (Co-investigator) Watson, David (Co-investigator)
- 01-Jan-2020 - 31-Jan-2024
- Prevention of CXCL12 production in cells of the cardiovascular system by IKK alpha inhibition (BHF PhD Studentship)
- Plevin, Robin (Principal Investigator) Coats, Paul (Co-investigator) MacKay, Simon (Co-investigator) Paul, Andrew (Co-investigator)
- 01-Jan-2018 - 30-Jan-2022
- A proof-of-concept study to establish a systematic approach for the discovery of allosteric sites in proteins
- Anthony, Nahoum Guillaume Hsuan (Principal Investigator) Paul, Andrew (Co-investigator)
- 05-Jan-2015 - 31-Jan-2017
- CXCL12 as a assay system for IKKapha inhibitor drugs
- Plevin, Robin (Principal Investigator) Paul, Andrew (Co-investigator)
- 01-Jan-2015 - 31-Jan-2017
- UNDERSTANDING THE EFFECTS OF CANCER RADIATION THERAPY ON ENDOTHELIAL CELL DYSFUNCTION- THE ROLE OF NUCLEAR FACTOR KAPPPA B
- Plevin, Robin (Principal Investigator) Boyd, Marie (Co-investigator) Paul, Andrew (Co-investigator)
- Understanding the effects of cancer radiation therapy on endothelial cell dysfunction- the role of Nuclear factor kapppa B
- 01-Jan-2013 - 30-Jan-2016
Contact
Dr
Andrew
Paul
Senior Lecturer
Strathclyde Institute of Pharmacy and Biomedical Sciences
Email: a.paul@strath.ac.uk
Tel: 548 2028